AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders…
News
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders…
Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin…
Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin…
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
BOSTON, April 11, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage…
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
BOSTON, April 11, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage…
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE)…
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE)…
Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP)
MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP)
MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Cleantech Blue-Zone Technologies Signs Agreement With Respirair Global
Blue-Zone to install its patented anesthetic capture technology in Respirair manufacturing facility TORONTO, April 11,…
Cleantech Blue-Zone Technologies Signs Agreement With Respirair Global
Blue-Zone to install its patented anesthetic capture technology in Respirair manufacturing facility TORONTO, April 11,…
Humacyte Completes Enrollment in Phase 3 Trial of Human Acellular Vessel™ (HAV™) for Hemodialysis Access in End-Stage Renal Disease Patients
DURHAM, N.C., April 11, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
Humacyte Completes Enrollment in Phase 3 Trial of Human Acellular Vessel™ (HAV™) for Hemodialysis Access in End-Stage Renal Disease Patients
DURHAM, N.C., April 11, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
STOUGHTON, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
STOUGHTON, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
Clene Announces the Plenary Presentations of MS and ALS Data Supporting the Efficacy and Safety of CNM-Au8® at the 2023 American Academy of Neurology Annual Meeting
SALT LAKE CITY, April 11, 2023 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…
Clene Announces the Plenary Presentations of MS and ALS Data Supporting the Efficacy and Safety of CNM-Au8® at the 2023 American Academy of Neurology Annual Meeting
SALT LAKE CITY, April 11, 2023 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…